Cognizin® Improves Memory in a New Biofortis Research Study
Our findings suggest that regular consumption of Cognizin® may be safe and potentially beneficial against memory loss due to aging.
COVID-19 has emphasized the need to adhere to protocol, clean data, and keeping participants and staff safe and healthy.
Our findings suggest that regular consumption of Cognizin® may be safe and potentially beneficial against memory loss due to aging.
Why new methods to collect clinical trial data, especially in view of the COVID-19 pandemic, should be considered.
As the COVID-19 situation continues to evolve, Biofortis is taking action for the safety of our community and our team.